Harmony Biosciences
HRMY
HRMY
182 hedge funds and large institutions have $2.29B invested in Harmony Biosciences in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 62 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+1
Holders Change %
+0.55%
% of All Funds
3.08%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.12%
New
30
Increased
72
Reduced
62
Closed
25
Calls
$3.6M
Puts
$292K
Net Calls
+$3.31M
Net Calls Change
+$3.53M
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$28.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.8M |
| 3 |
PA
Perceptive Advisors
New York
|
+$20.1M |
| 4 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
+$18.8M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
+$14.8M |
Top Sellers
| 1 |
NP
Newlight Partners
New York
|
-$30.2M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$23.2M |
| 3 |
ACM
Aisling Capital Management
New York
|
-$16.7M |
| 4 |
Two Sigma Investments
New York
|
-$9.41M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$8.77M |
